AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Inflation data and hawkish Fed messaging dominate markets this week as investors weigh mortgage rates and the path of...
Nvidia Chief Executive Jensen Huang indicated the company plans to cap its OpenAI investment well below $100 billion ...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...
As July 1 approaches, caps on federal student loan borrowing under the One Big Beautiful Bill Act threaten graduate a...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...
Apple introduces its most affordable devices to date, with price points starting at $599. The move targets price-cons...
Stocks waver as the 10-Year Treasury yield breaks higher, pushing mortgage rates headed higher. Analysts warn borrowe...
Memory stocks exploded 1,000% last year as AI demand surged. Analysts say silver and copper could be next AI benefici...
Keller Williams announced an agreement to acquire the Jason Mitchell Group, marking a pivotal shift in the evolving b...
A new nationwide survey finds some households earning more than $300,000 a year report paycheck-to-paycheck constrain...
Major cookware brands file a high-stakes lawsuit against a startup over claims that nonstick pans are toxic, signalin...